{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:39:23Z","timestamp":1787495963233,"version":"build-2736575974"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,23]]},"DOI":"10.7759\/cureus.99972","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T06:12:49Z","timestamp":1766556769000},"source":"Crossref","is-referenced-by-count":1,"title":["Ketamine-Induced Cholangiopathy With Concomitant Hemorrhagic Cystitis: An Emerging and Underrecognized Cause of Cholestasis"],"prefix":"10.7759","author":[{"given":"Kamran","family":"Nazir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqas","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Rafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeel","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim","family":"Khaleeq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos P","year":"2018","unstructured":"Zanos P, Moaddel R, Morris PJ, et al.. Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms. Pharmacol Rev. 2018, 70:621-60. 10.1124\/pr.117.015198","journal-title":"Pharmacol Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.7.853","article-title":"Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes","volume":"30","author":"Hijazi Y","year":"2002","unstructured":"Hijazi Y, Boulieu R. Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos. 2002, 30:853-8. 10.1124\/dmd.30.7.853","journal-title":"Drug Metab Dispos"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.01.041","article-title":"Liver injury is common among chronic abusers of ketamine","volume":"12","author":"Wong GL","year":"2014","unstructured":"Wong GL, Tam YH, Ng CF, et al.. Liver injury is common among chronic abusers of ketamine. Clin Gastroenterol Hepatol. 2014, 12:1759-62.e1. 10.1016\/j.cgh.2014.01.041","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.485","article-title":"Ketamine-induced cholangiopathy: a case report","volume":"106","author":"Seto WK","year":"2011","unstructured":"Seto WK, Ng M, Chan P, et al.. Ketamine-induced cholangiopathy: a case report. Am J Gastroenterol. 2011, 106:1004-5. 10.1038\/ajg.2010.485","journal-title":"Am J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-016-0081-2","article-title":"Risks associated with misuse of ketamine as a rapid-acting antidepressant","volume":"32","author":"Zhu W","year":"2016","unstructured":"Zhu W, Ding Z, Zhang Y, Shi J, Hashimoto K, Lu L. Risks associated with misuse of ketamine as a rapid-acting antidepressant. Neurosci Bull. 2016, 32:557-64. 10.1007\/s12264-016-0081-2","journal-title":"Neurosci Bull"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-021-01120-9","article-title":"Repeated or continuous medically supervised ketamine administration associated with hepatobiliary adverse events: a retrospective case series","volume":"44","author":"Cotter S","year":"2021","unstructured":"Cotter S, Wong J, Gada N, et al.. Repeated or continuous medically supervised ketamine administration associated with hepatobiliary adverse events: a retrospective case series. Drug Saf. 2021, 44:1365-74. 10.1007\/s40264-021-01120-9","journal-title":"Drug Saf"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2004.00525.x","article-title":"Microinjection of glutamate into dorsal motor nucleus of the vagus excites gallbladder motility through NMDA receptor - nitric oxide - cGMP pathway","volume":"16","author":"Liu CY","year":"2004","unstructured":"Liu CY, Xie DP, Liu JZ. Microinjection of glutamate into dorsal motor nucleus of the vagus excites gallbladder motility through NMDA receptor - nitric oxide - cGMP pathway. Neurogastroenterol Motil. 2004, 16:347-53. 10.1111\/j.1365-2982.2004.00525.x","journal-title":"Neurogastroenterol Motil"},{"key":"ref8","article-title":"Ketamine","year":"2012","unstructured":"Ketamine. LiverTox. Clinical and Research Information on Drug-Induced Liver Injury [Internet]. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda (MD); 2012."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-024-04421-6","article-title":"Features of biliary tract diseases in ketamine abusers: a systematic review of case reports","volume":"18","author":"Teymouri A","year":"2024","unstructured":"Teymouri A, Nasoori H, Fakheri M, Nasiri A. Features of biliary tract diseases in ketamine abusers: a systematic review of case reports. J Med Case Rep. 2024, 18:84. 10.1186\/s13256-024-04421-6","journal-title":"J Med Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7326\/aimcc.2023.0993","article-title":"A case series of recreational ketamine-induced cholangiopathy","volume":"3","author":"Garkusha LK","year":"2024","unstructured":"Garkusha LK, Lin Z, Lee LA. A case series of recreational ketamine-induced cholangiopathy. Ann Intern Med Clin Cases. 2024, 3:10.7326\/aimcc.2023.0993","journal-title":"Ann Intern Med Clin Cases"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-202476","article-title":"Rare case of severe cholangiopathy following critical illness","volume":"2014","author":"Patel KV","year":"2014","unstructured":"Patel KV, Zaman S, Chang F, Wilkinson M. Rare case of severe cholangiopathy following critical illness. BMJ Case Rep. 2014, 2014:10.1136\/bcr-2013-202476","journal-title":"BMJ Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-BSG.363","article-title":"Ketamine cholangiopathy: largest UK single-centre case series reporting clinical outcomes in 36 patients","author":"Arms-Williams B","year":"2025","unstructured":"Arms-Williams B, Perkins J, Wiles R, Moore K, Richardson P. Ketamine cholangiopathy: largest UK single-centre case series reporting clinical outcomes in 36 patients. Gut. 2025, 10.1136\/gutjnl-2025-BSG.363","journal-title":"Gut"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/434123-ketamine-induced-cholangiopathy-with-concomitant-hemorrhagic-cystitis-an-emerging-and-underrecognized-cause-of-cholestasis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T06:12:52Z","timestamp":1766556772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/434123-ketamine-induced-cholangiopathy-with-concomitant-hemorrhagic-cystitis-an-emerging-and-underrecognized-cause-of-cholestasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.99972","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,23]]}}}